RPG Life Sciences Limited

Equities

RPGLIFE

INE105J01010

Pharmaceuticals

Market Closed - NSE India S.E. 07:42:31 2024-04-30 am EDT 5-day change 1st Jan Change
1,546 INR -0.91% Intraday chart for RPG Life Sciences Limited +0.40% +15.76%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Chart RPG Life Sciences Limited
More charts
RPG Life Sciences Limited is an India-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has presence in over 10 therapeutic areas, including nephrology, oncology, rheumatology, cardiology, respiratory, nutritional, gastroenterology, and diabetology, among others. The international formulations business is involved in developing, manufacturing and marketing oral solid formulations in the generic and branded generic space across regulated and emerging markets. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Sodium Valproate PR, Nicorandil, Quinfamide, Nicorandil, Haloperidol, Risperidone, and others.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RPGLIFE Stock
  4. News RPG Life Sciences Limited
  5. ICRA Lifts Rating on RPG Life Sciences' Long-term Financing to A+; Shares Jump 3%